var data={"title":"Epidemiology, microbiology, and pathogenesis of tularemia","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Epidemiology, microbiology, and pathogenesis of tularemia</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/contributors\" class=\"contributor contributor_credentials\">Robert L Penn, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/contributors\" class=\"contributor contributor_credentials\">Stephen B Calderwood, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/contributors\" class=\"contributor contributor_credentials\">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/contributors\" class=\"contributor contributor_credentials\">Allyson Bloom, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 17, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H274969625\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Tularemia is the zoonotic infection caused by <em>Francisella tularensis</em>, an aerobic and fastidious gram-negative bacterium. Human infection occurs following contact with infected animals or invertebrate vectors. Synonyms include Francis' disease, deer-fly fever, rabbit fever, water-rat trappers' disease, wild hare disease (yato-byo), and Ohara's disease [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/1\" class=\"abstract_t\">1</a>].</p><p>The epidemiology, microbiology, and pathogenesis of infection due to <em>F. tularensis</em> will be reviewed here. The clinical manifestations, diagnosis, treatment, and prevention of tularemia are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-tularemia\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of tularemia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H29154667\"><span class=\"h1\">EPIDEMIOLOGY</span></p><p class=\"headingAnchor\" id=\"H1018817150\"><span class=\"h2\">Distribution</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The majority of infections in humans and animals are caused by <em>F. tularensis</em> subspecies <em>tularensis</em> (the more virulent species) and <em>F. tularensis</em> subspecies <em>holarctica</em>. Human disease is rarely associated with the subspecies <em>novicida</em>, <em>Francisella philomiragia</em>, and <em>Francisella hispaniensis</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/1-3\" class=\"abstract_t\">1-3</a>].</p><p>In North America, <em>F. tularensis</em> has been described in the United States, Canada, and Mexico. In the United States, the majority of cases traditionally occur in the south-central states (<a href=\"image.htm?imageKey=ID%2F68457\" class=\"graphic graphic_figure graphicRef68457 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/4\" class=\"abstract_t\">4</a>]. Over time, however, the southern border of tularemia in the United States has shifted northward [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/5\" class=\"abstract_t\">5</a>]. As an example, the number of reported cases in Colorado, Nebraska, South Dakota, and Wyoming dramatically increased in 2015, and 74 percent of cases occurred in Arkansas, Colorado, Kansas, Missouri, Nebraska, Oklahoma, South Dakota, and Wyoming (<a href=\"image.htm?imageKey=ID%2F65498\" class=\"graphic graphic_figure graphicRef65498 \">figure 2</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/6\" class=\"abstract_t\">6</a>]. This is consistent with the predicted effects of climate change on the geographic distribution of tularemia [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/7\" class=\"abstract_t\">7</a>].</p><p>Other countries known to have endemic tularemia include most European countries, the former Soviet Union, Tunisia, Turkey, Israel, Iran, China, and Japan. Tularemia is relatively uncommon in African countries, Australia, England, and South American countries.</p><p><em>F. tularensis</em> subspecies <em>tularensis</em> accounts for approximately 90 percent of human infections in North America. In other parts of the world, <em>F. tularensis</em> subspecies <em>holarctica</em> is the more common cause of infection. Specific strains of <em>F. tularensis</em> subspecies <em>tularensis</em> may be relatively restricted in their locations, although subspecies <em>holarctica</em> strains are more geographically dispersed [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/8\" class=\"abstract_t\">8</a>]. Within a single region, animal and human outbreaks may involve multiple <em>F. tularensis</em> types [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/9,10\" class=\"abstract_t\">9,10</a>].</p><p>The organism infects more than 100 species of wild and domestic vertebrates and over 100 species of invertebrates. In the United States, important mammals include lagomorphs and rodents, such as rabbits, beavers, muskrats, squirrels, and voles. In Europe, important mammals include hares, hamsters, mice, rats, beavers, lemmings, and voles. Animals vary in their susceptibility and response to infection. Some lagomorphs and rodents, such as rabbits, tend to develop a fatal illness when infected, while many other species develop infection but do not succumb to the illness. </p><p><em>Francisella</em> is hardy in nature (though it can be difficult to isolate in the laboratory). The organism can persist in animal carcasses, mud, or water for several weeks.</p><p class=\"headingAnchor\" id=\"H29154715\"><span class=\"h2\">Sources of human infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Humans may acquire infection by several routes and manifest a variety of clinical syndromes. Overall, laboratory workers, farmers, veterinarians, hunters, landscapers, and meat handlers are among the occupations that have an increased risk for tularemia. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-tularemia\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of tularemia&quot;</a>.)</p><p>Transmission to humans occurs from contact with a contaminated animal or a biting insect. Overall, tick exposure during the summer months is the most commonly recognized mode of transmission in the United States, particularly in children [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/4\" class=\"abstract_t\">4</a>]. Other insect vectors include mosquitoes, horse flies, fleas, and lice [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/11\" class=\"abstract_t\">11</a>]. In California, Nevada, and Utah, biting flies are the predominant insect vectors, while, in areas east of these states, ticks are the predominant vectors. In Finland, Sweden, and areas of the former Soviet Union, mosquitoes are the important insect vectors [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/12\" class=\"abstract_t\">12</a>]. <em>F. tularensis</em> may be passed transstadially (ie, across life stages) in ticks. However, studies attempting to demonstrate transovarial transmission have found conflicting results [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/13\" class=\"abstract_t\">13</a>].</p><p>Transmission of human infection also can occur from handling infected animals, splashing infected material into the eyes, or rubbing the eyes with contaminated fingers. The trade in wild animals as pets is another potential source [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/14\" class=\"abstract_t\">14</a>]. Carnivores, such as domestic cats and, in at least one instance, a bird, may transmit tularemia through carriage of the organism on claws or in the mouth [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/1,15\" class=\"abstract_t\">1,15</a>]. A single case of tularemia pneumonia associated with an infected pet dog has also been described [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/16\" class=\"abstract_t\">16</a>].</p><p>Contaminated meat and water remain important environmental sources for transmission, and the disruptions caused by natural disasters or wars have been associated with tularemia outbreaks caused by the ingestion of contaminated food and water. Transmission from unchlorinated drinking water during several different outbreaks in Turkey has been confirmed using whole genome sequencing [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/17\" class=\"abstract_t\">17</a>]. Survival of <em>F. tularensis</em> in water can be prolonged, even if the water is brackish or frozen [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/1,18\" class=\"abstract_t\">1,18</a>]. Perhaps important to its persistence in water is the ability of the organism to multiply within <em>Acanthamoeba castellanii</em>, to induce encystation, and to survive within amoebal cysts [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/19\" class=\"abstract_t\">19</a>].</p><p>Transmission can occur from airborne spread of contaminated materials, including dust, hay, and water, as well as laboratory specimens. Airborne transmission was the suspected source of an outbreak of pneumonic tularemia in 2000 on Martha's Vineyard, Massachusetts; lawn mowing or cutting brush were risk factors for acquiring the infection [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/20\" class=\"abstract_t\">20</a>]. <em>F. tularensis</em> has been identified as a category A bioterrorism agent by the Centers for Disease Control and Prevention. A weapon using airborne <em>F. tularensis</em> would most likely result in an outbreak of inhalational tularemia three to five days later, marked by an acute, undifferentiated febrile illness with predominant manifestations of pneumonia, pleuritis, and hilar lymphadenopathy [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/21\" class=\"abstract_t\">21</a>]. Other clinical forms of tularemia would also occur, including typhoidal, pharyngeal, and ocular tularemia [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/1,21\" class=\"abstract_t\">1,21</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-tularemia\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of tularemia&quot;</a>.)</p><p>Clustered cases occurring without the expected epidemiologic exposures to animals, insects, or environmental activities should raise the possibility of a bioterrorism event. Specific epidemiological, clinical, and microbiological clues should lead to early suspicion of intentional tularemia and rapid activation of the health alert system, since laboratory confirmation of the agent could be delayed. </p><p class=\"headingAnchor\" id=\"H274969632\"><span class=\"h1\">MICROBIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The <em>Francisella</em> genus includes the potential human pathogens <em>F. tularensis</em>, <em>Francisella philomiragia</em>, and <em>Francisella hispaniensis </em>[<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/22,23\" class=\"abstract_t\">22,23</a>]. There are also the fish pathogens <em>Francisella noatunensis</em> and <em>Francisella halioticida</em>, and many environmental isolates. Some environmental species previously placed in the <em>Francisella</em> genus have been reclassified in a new genus, <em>Allofrancisella</em>, including <em>A.</em> <em>guangzhouensis</em> (previously <em>Francisella guangzhouensis</em>) [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/24\" class=\"abstract_t\">24</a>]. Other <em>Francisella</em> species, some not officially named, have also rarely caused human infections [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/25\" class=\"abstract_t\">25</a>].</p><p>The subspecies of <em>F. tularensis</em> are <em>F. tularensis</em> subspecies <em>tularensis</em> (also called <em>F. tularensis</em> type A or <em>Francisella neoarctica</em>), <em>F. tularensis</em> subspecies <em>holarctica</em> (also called <em>F. tularensis</em> type B), <em>F. tularensis</em> subspecies <em>novicida</em> (also called <em>Francisella novicida </em>by some since its classification as a subspecies of <em>F. tularensis</em> has been controversial), and <em>F. tularensis</em> subspecies <em>mediasiatica</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/1,3,26\" class=\"abstract_t\">1,3,26</a>]. In addition, molecular typing methods have identified distinct clades or genotypes of <em>F. tularensis</em> subspecies <em>tularensis</em> that differ in their geographic locations and virulence [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/8,27\" class=\"abstract_t\">8,27</a>].</p><p><em>Francisella</em> spp are small, pale-staining, slow-growing, aerobic, gram-negative coccobacilli. Growth in the laboratory is optimal at 35&deg; C, with or without carbon dioxide supplementation. The organisms are fastidious and infrequently isolated from clinical specimens [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/3\" class=\"abstract_t\">3</a>]. Most strains require cysteine or cystine for growth, but strains that are less fastidious or lack a cysteine requirement have been described [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/28\" class=\"abstract_t\">28</a>]. <em>F. tularensis</em> grows on some commercial media, including chocolate agar, modified Thayer-Martin media, and buffered charcoal-yeast extract agar [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/3\" class=\"abstract_t\">3</a>]. Isolates suspicious for <em>F. tularensis</em> can be characterized as tiny, poorly-staining, gram-negative coccobacilli that are slow growing, grow better on chocolate agar than on blood agar, do not grow on routine gram-negative selective media, are oxidase negative, catalase negative or weakly catalase positive, beta-lactamase positive, and satellite or XV test negative [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/29\" class=\"abstract_t\">29</a>]. </p><p>Because <em>F. tularensis</em> is difficult to grow and dangerous to handle, laboratory personnel should be notified whenever tularemia is considered. Routine specimens may be processed in the clinical laboratory using Biosafety Level 2 precautions [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/30\" class=\"abstract_t\">30</a>]. However, any isolate suspected of being <em>F. tularensis</em> should be handled using Biosafety Level 3 precautions, and immediately referred to the state public health laboratory or another appropriate Laboratory Response Network facility for further evaluation [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/30\" class=\"abstract_t\">30</a>]. In particular, automated identification systems should not be used because they may generate aerosols and misidentify <em>F. tularensis</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/29\" class=\"abstract_t\">29</a>]. In addition, automated system misidentification of <em>Veillonella</em> as <em>F. tularensis</em> has been reported [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/31\" class=\"abstract_t\">31</a>]. Possession and shipment of <em>F. tularensis</em> is tightly restricted because of its potential as a bioterrorism agent, and appropriate federal regulations must be followed [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/1,29\" class=\"abstract_t\">1,29</a>].</p><p class=\"headingAnchor\" id=\"H274969639\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of infection with <em>F. tularensis</em> and its virulence factors have been the subject of intense investigation, in part because of the organism&rsquo;s potential use as an agent of bioterrorism. <em>F. tularensis</em> is a highly virulent organism; only 10 to 50 intradermal or inhaled organisms are required to produce clinical illness. <em>F. tularensis</em> subspecies <em>tularensis</em> (type A) in general causes a more severe clinical infection than subspecies <em>holarctica</em> (type B). Subspecies <em>tularensis</em> genotype A1b strains are more likely to be associated with invasive infections and have a higher mortality than type A1a, A2, or B strains [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/8\" class=\"abstract_t\">8</a>]. </p><p>After multiplying at the site of inoculation, <em>F. tularensis</em> spreads first to regional lymph nodes and may then spread systemically through a lymphohematogenous route. At sites of inoculation, there is an acute inflammatory reaction involving neutrophils, macrophages, and lymphocytes that results in tissue necrosis [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/32\" class=\"abstract_t\">32</a>]. Granulomas may form and occasionally caseate, mimicking tuberculosis. Despite this host reaction, <em>F. tularensis</em> may remain alive in tissues for some time.</p><p><em>F. tularensis</em> is a facultative intracellular pathogen that replicates primarily within host macrophages, but may also infect many other cell types [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/33-35\" class=\"abstract_t\">33-35</a>]. Adherence of <em>F. tularensis</em> to host cells is mediated by type IV pili <span class=\"nowrap\">and/or</span> other bacterial surface proteins [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/36\" class=\"abstract_t\">36</a>]. It has been shown that a type IV pilus subunit of subspecies <em>holarctica</em> is a ligand for ICAM-1 on rat vascular epithelial cells [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/37\" class=\"abstract_t\">37</a>]. Macrophage uptake of <em>F. tularensis</em> is a unique process called &quot;looping phagocytosis&quot; that involves asymmetric and spacious pseudopod loops [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/38\" class=\"abstract_t\">38</a>]. Entry into macrophages is dependent upon complement and complement receptors; alternative pathways involve mannose receptors and class A scavenger receptors. <em>F. tularensis</em> also may be directly transferred from infected cells to uninfected macrophages during a contact-dependent exchange of cytosolic material associated with trogocytosis [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/39\" class=\"abstract_t\">39</a>]. After being taken up, phagosome maturation and phagosome-lysosome fusion are impaired, and <em>F. tularensis</em> quickly escapes into the cytosol. <em>Francisella</em> multiply in the cytosol, induce macrophage cell death, and are released to further spread the infection. Similar events occur in neutrophils [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/40\" class=\"abstract_t\">40</a>]. After phagocytosis, human neutrophils are unable to kill <em>F. tularensis</em>; the organism inhibits NADPH oxidase, the oxidative burst is suppressed, and the organism escapes into the neutrophil cytoplasm [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/39,40\" class=\"abstract_t\">39,40</a>]. <em>F. tularensis</em> also can inhibit apoptosis of neutrophils and prolong survival of infected neutrophils.</p><p>In a mouse model of <em>F. tularensis</em> infection, most organisms recovered from blood were not in leukocytes but, rather, free in plasma [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/41\" class=\"abstract_t\">41</a>]. This was independent of the inoculum size, virulence, or route of administration. The organisms grew well in whole blood but not in plasma, suggesting a requirement for host cells. These observations suggest that <em>F. tularensis</em> in the blood may be taken up by leukocytes where it replicates, and then escapes into the plasma where it can begin a cycle of reinfection. It has also been shown that <em>F. tularensis</em> can infect erythrocytes and persist within them. Intraerythrocytic organisms are protected from killing by <a href=\"topic.htm?path=gentamicin-drug-information\" class=\"drug drug_general\">gentamicin</a>, perhaps contributing to relapse after inadequate treatment [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/42\" class=\"abstract_t\">42</a>]. Furthermore, intraerythrocytic <em>F. tularensis</em> are protected from the acidic pH of the tick gut; this enhances tick colonization by the organism [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/43\" class=\"abstract_t\">43</a>].</p><p>An early, innate host response functions to contain infection prior to the development of acquired immunity, but is not sufficient to clear the infection. Within the macrophage cytosol, organisms activate a host-protective multimolecular complex, the inflammasome, leading to the release of proinflammatory cytokines (interleukin-1 beta and interleukin-18) that trigger caspase-1 dependent cell death [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/44\" class=\"abstract_t\">44</a>]. These effects require type I interferon signaling. Other mechanisms involved in the innate immune response include neutrophils, macrophages, dendritic cells, NK cells, lymphocytes, interleukin-12, tumor necrosis factor-alpha, interferon gamma, and Toll-like receptor 2 [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/34\" class=\"abstract_t\">34</a>]. Natural antibody responses to carbohydrate antigens occur after the development of cellular immunity, and are insufficient to protect against infection [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/45\" class=\"abstract_t\">45</a>]. In contrast, recovery from infection is dependent upon the development of cell-mediated immunity. Cell-mediated immunity is directed against protein antigens and is dependent upon CD4<sup>+</sup> and CD8<sup>+</sup> T-cells [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/34,46\" class=\"abstract_t\">34,46</a>]. As a consequence, macrophages are activated to kill intracellular <em>F. tularensis</em> through a process that involves tumor necrosis factor-alpha, interferon gamma, and the production of reactive nitrogen products [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/46\" class=\"abstract_t\">46</a>]. Both humoral and cellular mechanisms contribute to optimize protective immunity in mice, but their relative importance in humans is unknown.</p><p>The virulence of <em>F. tularensis</em> has been correlated with several of its phenotypic characteristics, including encapsulation, LPS, pili, and production of acid phosphatases and a siderophore [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/34,47\" class=\"abstract_t\">34,47</a>]. Subsequently, genomic studies have identified specific genetic correlates of virulence, including a cluster of genes known as the <em>Francisella</em> pathogenicity island (FPI) [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/34\" class=\"abstract_t\">34</a>]. Many of the FPI genes are involved in animal virulence and intracellular survival, and are induced by intracellular growth of the organism. FPI genes are under transcriptional regulation responsive to environmental factors, including intracellular growth, iron limitation, and oxidative stress. In addition to preventing phagosome-lysosome fusion and intracellular killing, <em>F. tularensis</em> is capable of delaying, suppressing, or avoiding many other host immune responses to its presence. These include poor recognition of <em>F. tularensis</em> LPS by TLR4, repression of the host cell inflammasome, destabilization of host cell mRNA and impairment of proinflammatory cytokine production, and the induction of PGE2 secretion that can inhibit interferon gamma production [<a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/48-52\" class=\"abstract_t\">48-52</a>].</p><p class=\"headingAnchor\" id=\"H274969660\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tularemia is a zoonotic infection caused by the gram-negative bacterium <em>Francisella tularensis</em>. Human infection occurs following contact with infected animals or invertebrate vectors. (See <a href=\"#H274969625\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the United States, the majority of cases have occurred in Arkansas, Colorado, Kansas, Missouri, Nebraska, Oklahoma, South Dakota, and Wyoming. Other countries known to have endemic tularemia include Canada, Mexico, most European countries, the former Soviet Union, Tunisia, Turkey, Israel, Iran, China, and Japan. (See <a href=\"#H29154667\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>F. tularensis</em> infects more than 100 species of wild and domestic vertebrates and over 100 species of invertebrates. Insect vectors include ticks, mosquitoes, horse flies, fleas, and lice. Rodents and lagomorphs, such as rabbits, tend to develop a fatal illness when infected, while many other species develop infection but do not succumb to the illness. The organism may survive in animal carcasses, mud, and water for several weeks. (See <a href=\"#H29154667\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Transmission of infection to humans can occur from invertebrate vectors, handling infected animals, ingesting contaminated foods, drinking contaminated water, animal bites or scratches, splashing infected material into the eyes, and rubbing the eyes with contaminated fingers. Transmission also can occur from airborne spread of contaminated materials, including dust, hay, and water. (See <a href=\"#H29154715\" class=\"local\">'Sources of human infection'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vector-borne disease (especially by ticks, but also by flies) has become the most common mode of transmission in the United States. In some European countries, mosquito-borne disease predominates. (See <a href=\"#H29154715\" class=\"local\">'Sources of human infection'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>F. tularensis</em> has been identified as a category A bioterrorism agent by the Centers for Disease Control and Prevention. A weapon using airborne <em>F. tularensis</em> would most likely result in an outbreak of inhalational tularemia three to five days later, marked by an acute, undifferentiated febrile illness with predominant manifestations of pneumonia, pleuritis, and hilar lymphadenopathy. Clustered cases occurring without the expected epidemiologic exposures to animals, insects, or environmental activities should suggest the possibility of a bioterrorism event. (See <a href=\"#H29154715\" class=\"local\">'Sources of human infection'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>F. tularensis</em> is difficult to grow and dangerous to handle; therefore, laboratory personnel should be notified whenever tularemia is considered or suspected. (See <a href=\"#H274969632\" class=\"local\">'Microbiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>F. tularensis</em> is a facultative intracellular pathogen that replicates primarily within host macrophages by impairing phagosome maturation and phagosome-lysosome fusion. <em>F. tularensis</em> also is capable of delaying, suppressing, or avoiding many other host immune responses to its presence. Recovery from infection depends on development of host cell mediated immunity. (See <a href=\"#H274969639\" class=\"local\">'Pathogenesis'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">Penn RL. Francisella tularensis (Tularemia). In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 8th ed, Bennet JE, Dolin R, Blaser MJ (Eds), Elsevier Saunders, Philadelphia 2015. p.2590.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/2\" class=\"nounderline abstract_t\">Brett ME, Respicio-Kingry LB, Yendell S, et al. Outbreak of Francisella novicida bacteremia among inmates at a louisiana correctional facility. Clin Infect Dis 2014; 59:826.</a></li><li class=\"breakAll\">Peterson JM, Schriefer ME. Francisella. In: Manual of Clinical Microbiology, 11th ed, Jorgensen J, Pfaller M, Carroll K, et al (Eds), American Society for Microbiology Press, Washington DC 2015.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/4\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Tularemia - Missouri, 2000-2007. MMWR Morb Mortal Wkly Rep 2009; 58:744.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/5\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Tularemia - United States, 2001-2010. MMWR Morb Mortal Wkly Rep 2013; 62:963.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/6\" class=\"nounderline abstract_t\">Adams DA, Thomas KR, Jajosky RA, et al. Summary of Notifiable Infectious Diseases and Conditions - United States, 2015. MMWR Morb Mortal Wkly Rep 2017; 64:1.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/7\" class=\"nounderline abstract_t\">Nakazawa Y, Williams R, Peterson AT, et al. Climate change effects on plague and tularemia in the United States. Vector Borne Zoonotic Dis 2007; 7:529.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/8\" class=\"nounderline abstract_t\">Kugeler KJ, Mead PS, Janusz AM, et al. Molecular Epidemiology of Francisella tularensis in the United States. Clin Infect Dis 2009; 48:863.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/9\" class=\"nounderline abstract_t\">Petersen JM, Carlson JK, Dietrich G, et al. Multiple Francisella tularensis subspecies and clades, tularemia outbreak, Utah. Emerg Infect Dis 2008; 14:1928.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/10\" class=\"nounderline abstract_t\">Johansson A, L&auml;rkeryd A, Widerstr&ouml;m M, et al. An outbreak of respiratory tularemia caused by diverse clones of Francisella tularensis. Clin Infect Dis 2014; 59:1546.</a></li><li class=\"breakAll\">Acha PN, Szyfres B. Tularemia. In: Zoonosis and Communicable Disease Common to Man and Animals, Pan American Health Organization, Washington DC 2001. Vol 1, p.275.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/12\" class=\"nounderline abstract_t\">Ryd&eacute;n P, Bj&ouml;rk R, Sch&auml;fer ML, et al. Outbreaks of tularemia in a boreal forest region depends on mosquito prevalence. J Infect Dis 2012; 205:297.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/13\" class=\"nounderline abstract_t\">Genchi M, Prati P, Vicari N, et al. Francisella tularensis: No Evidence for Transovarial Transmission in the Tularemia Tick Vectors Dermacentor reticulatus and Ixodes ricinus. PLoS One 2015; 10:e0133593.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/14\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Outbreak of tularemia among commercially distributed prairie dogs, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:688, 699.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/15\" class=\"nounderline abstract_t\">Padeshki PI, Ivanov IN, Popov B, Kantardjiev TV. The role of birds in dissemination of Francisella tularensis: first direct molecular evidence for bird-to-human transmission. Epidemiol Infect 2010; 138:376.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/16\" class=\"nounderline abstract_t\">Yaglom H, Rodriguez E, Gaither M, et al. Notes from the Field: Fatal Pneumonic Tularemia Associated with Dog Exposure - Arizona, June 2016. MMWR Morb Mortal Wkly Rep 2017; 66:891.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/17\" class=\"nounderline abstract_t\">Karadenizli A, Forsman M, &#350;im&#351;ek H, et al. Genomic analyses of Francisella tularensis strains confirm disease transmission from drinking water sources, Turkey, 2008, 2009 and 2012. Euro Surveill 2015; 20.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/18\" class=\"nounderline abstract_t\">Berrada ZL, Telford Iii SR. Survival of Francisella tularensis Type A in brackish-water. Arch Microbiol 2011; 193:223.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/19\" class=\"nounderline abstract_t\">El-Etr SH, Margolis JJ, Monack D, et al. Francisella tularensis type A strains cause the rapid encystment of Acanthamoeba castellanii and survive in amoebal cysts for three weeks postinfection. Appl Environ Microbiol 2009; 75:7488.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/20\" class=\"nounderline abstract_t\">Feldman KA, Enscore RE, Lathrop SL, et al. An outbreak of primary pneumonic tularemia on Martha's Vineyard. N Engl J Med 2001; 345:1601.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/21\" class=\"nounderline abstract_t\">Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001; 285:2763.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/22\" class=\"nounderline abstract_t\">Kugeler KJ, Mead PS, McGowan KL, et al. Isolation and characterization of a novel Francisella sp. from human cerebrospinal fluid and blood. J Clin Microbiol 2008; 46:2428.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/23\" class=\"nounderline abstract_t\">Respicio-Kingry LB, Byrd L, Allison A, et al. Cutaneous infection caused by a novel Francisella sp. J Clin Microbiol 2013; 51:3456.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/24\" class=\"nounderline abstract_t\">Qu PH, Li Y, Salam N, et al. Allofrancisella inopinata gen. nov., sp. nov. and Allofrancisella frigidaquae sp. nov., isolated from water-cooling systems, and transfer of Francisella guangzhouensis Qu et al. 2013 to the new genus as Allofrancisella guangzhouensis comb. nov. Int J Syst Evol Microbiol 2016; 66:4832.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/25\" class=\"nounderline abstract_t\">Challacombe JF, Petersen JM, Gallegos-Graves V, et al. Whole-Genome Relationships among Francisella Bacteria of Diverse Origins Define New Species and Provide Specific Regions for Detection. Appl Environ Microbiol 2017; 83.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/26\" class=\"nounderline abstract_t\">Gunnell MK, Adams BJ, Robison RA. The Genetic Diversity and Evolution of Francisella tularensis with Comments on Detection by PCR. Curr Issues Mol Biol 2016; 18:79.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/27\" class=\"nounderline abstract_t\">Birdsell DN, Johansson A, &Ouml;hrman C, et al. Francisella tularensis subsp. tularensis group A.I, United States. Emerg Infect Dis 2014; 20:861.</a></li><li class=\"breakAll\">Sj&ouml;stedt AB. Francisella. In: Bergey's Manual of Systematic Bacteriology, 2nd ed, Brenner DJ, Krieg NR, Staley JT (Eds), Springer-Verlag, New York 2005. Vol 2, p.200.</li><li class=\"breakAll\">American Society for Microbiology (ASM). Sentinel level clinical laboratory guidelines for suspected agents of bioterrorism and emerging infectious diseases: Francisella tularensis. Revised March 2016. https://www.asm.org/images/PSAB/LRN/Tularemia316.pdf (Accessed on September 04, 2017).</li><li class=\"breakAll\">Section IV&mdash;Laboratory Biosafety Level Criteria. In: Biosafety in Microbiological and Biomedical Laboratories, 5th Ed. Chosewood LC, Wilson D (Eds), CDC, 2009; 30. https://www.cdc.gov/biosafety/publications/bmbl5/bmbl5_sect_iv.pdf#x2013;%20Laboratory%20Biosafety%20Level%20CriteriaSection%20IV&mdash;Laboratory%20Biosafety%20Level%20Criteria%20[PDF%20-%20354%20KB]&lt;/a&gt; (Accessed on September 04, 2017).</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/31\" class=\"nounderline abstract_t\">Carter KK, Peterson EM, Voermans RL, et al. Notes from the Field: Veillonella Misidentified as Francisella tularensis - Idaho, 2016. MMWR Morb Mortal Wkly Rep 2017; 66:564.</a></li><li class=\"breakAll\">Geyer SJ, Burkey A, Chandler FW. Tularemia. In: Pathology of Infectious Diseases, Connor DH (Ed), Appleton &amp; Lange, Stamford, Conn 1997. p.869.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/33\" class=\"nounderline abstract_t\">Clemens DL, Horwitz MA. Uptake and intracellular fate of Francisella tularensis in human macrophages. Ann N Y Acad Sci 2007; 1105:160.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/34\" class=\"nounderline abstract_t\">Pechous RD, McCarthy TR, Zahrt TC. Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development. Microbiol Mol Biol Rev 2009; 73:684.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/35\" class=\"nounderline abstract_t\">Santic M, Al-Khodor S, Abu Kwaik Y. Cell biology and molecular ecology of Francisella tularensis. Cell Microbiol 2010; 12:129.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/36\" class=\"nounderline abstract_t\">Moreau GB, Mann BJ. Adherence and uptake of Francisella into host cells. Virulence 2013; 4:826.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/37\" class=\"nounderline abstract_t\">Bencurova E, Kovac A, Pulzova L, et al. Deciphering the protein interaction in adhesion of Francisella tularensis subsp. holarctica to the endothelial cells. Microb Pathog 2015; 81:6.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/38\" class=\"nounderline abstract_t\">Clemens DL, Lee BY, Horwitz MA. Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect Immun 2005; 73:5892.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/39\" class=\"nounderline abstract_t\">Steele S, Radlinski L, Taft-Benz S, et al. Trogocytosis-associated cell to cell spread of intracellular bacterial pathogens. Elife 2016; 5.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/40\" class=\"nounderline abstract_t\">Kinkead LC, Allen LA. Multifaceted effects of Francisella tularensis on human neutrophil function and lifespan. Immunol Rev 2016; 273:266.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/41\" class=\"nounderline abstract_t\">Forestal CA, Malik M, Catlett SV, et al. Francisella tularensis has a significant extracellular phase in infected mice. J Infect Dis 2007; 196:134.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/42\" class=\"nounderline abstract_t\">Horzempa J, O'Dee DM, Stolz DB, et al. Invasion of erythrocytes by Francisella tularensis. J Infect Dis 2011; 204:51.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/43\" class=\"nounderline abstract_t\">Schmitt DM, Barnes R, Rogerson T, et al. The Role and Mechanism of Erythrocyte Invasion byFrancisella tularensis. Front Cell Infect Microbiol 2017; 7:173.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/44\" class=\"nounderline abstract_t\">Henry T, Brotcke A, Weiss DS, et al. Type I interferon signaling is required for activation of the inflammasome during Francisella infection. J Exp Med 2007; 204:987.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/45\" class=\"nounderline abstract_t\">Kirimanjeswara GS, Golden JM, Bakshi CS, Metzger DW. Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis. J Immunol 2007; 179:532.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/46\" class=\"nounderline abstract_t\">Elkins KL, Cowley SC, Bosio CM. Innate and adaptive immunity to Francisella. Ann N Y Acad Sci 2007; 1105:284.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/47\" class=\"nounderline abstract_t\">Forslund AL, Salomonsson EN, Golovliov I, et al. The type IV pilin, PilA, is required for full virulence of Francisella tularensis subspecies tularensis. BMC Microbiol 2010; 10:227.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/48\" class=\"nounderline abstract_t\">Dotson RJ, Rabadi SM, Westcott EL, et al. Repression of inflammasome by Francisella tularensis during early stages of infection. J Biol Chem 2013; 288:23844.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/49\" class=\"nounderline abstract_t\">Bauler TJ, Chase JC, Wehrly TD, Bosio CM. Virulent Francisella tularensis destabilize host mRNA to rapidly suppress inflammation. J Innate Immun 2014; 6:793.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/50\" class=\"nounderline abstract_t\">Jones BD, Faron M, Rasmussen JA, Fletcher JR. Uncovering the components of the Francisella tularensis virulence stealth strategy. Front Cell Infect Microbiol 2014; 4:32.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/51\" class=\"nounderline abstract_t\">Steiner DJ, Furuya Y, Metzger DW. Host-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity. Infect Drug Resist 2014; 7:239.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-microbiology-and-pathogenesis-of-tularemia/abstract/52\" class=\"nounderline abstract_t\">Gillette DD, Curry HM, Cremer T, et al. Virulent Type A Francisella tularensis actively suppresses cytokine responses in human monocytes. Front Cell Infect Microbiol 2014; 4:45.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3130 Version 16.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H274969660\"><span>SUMMARY</span></a></li><li><a href=\"#H274969625\" id=\"outline-link-H274969625\">INTRODUCTION</a></li><li><a href=\"#H29154667\" id=\"outline-link-H29154667\">EPIDEMIOLOGY</a><ul><li><a href=\"#H1018817150\" id=\"outline-link-H1018817150\">Distribution</a></li><li><a href=\"#H29154715\" id=\"outline-link-H29154715\">Sources of human infection</a></li></ul></li><li><a href=\"#H274969632\" id=\"outline-link-H274969632\">MICROBIOLOGY</a></li><li><a href=\"#H274969639\" id=\"outline-link-H274969639\">PATHOGENESIS</a></li><li><a href=\"#H274969660\" id=\"outline-link-H274969660\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/3130|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/68457\" class=\"graphic graphic_figure\">- Reported cases of tularemia in United States from 2001-2010</a></li><li><a href=\"image.htm?imageKey=ID/65498\" class=\"graphic graphic_figure\">- Reported cases of tularemia in US in 2015</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-tularemia\" class=\"medical medical_review\">Clinical manifestations, diagnosis, and treatment of tularemia</a></li></ul></div></div>","javascript":null}